Kari Alitalo

Professor Alitalo is the Director of Translational Cancer Biology Research program at the University of Helsinki. He is an internationally leading expert in endothelial growth factors in cancer. His research group discovered VEGF-C, the growth factor that regulates lymphangiogenesis, and subsequently has shown that regulation of lymphangiogenesis can be used therapeutically to suppress lymph node metastasis but also to promote formation of new lymphatic vessels in lymphedema. He has published more than 500 articles in the fields of biomedicine, cancer research and cell and molecular biology. Professor Alitalo has received numerous international prizes, such as InBev-Baillet Latour International Health Prize, Louis Jeantet prize for Medicine, Anders Jahre prize, Dr. A.H. Heineken Prize and is a foreign associated member of the National Academy of Sciences if the USA.